Oragenics Inc. (OGEN)

0.60
AMEX : Health Technology
Prev Close 0.62
Day Low/High 0.56 / 0.64
52 Wk Low/High 0.38 / 3.74
Avg Volume 1.42M
Exchange AMEX
Shares Outstanding 29.45M
Market Cap 18.26M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
Top Insider Trades: OGEN, FOLD, ACHN, ZINC

Top Insider Trades: OGEN, FOLD, ACHN, ZINC

The top 10 open-market insider purchases and sales filed at the SEC Friday.

Oragenics Announces Completion Of Public Offering Of Common Stock

Oragenics Announces Completion Of Public Offering Of Common Stock

Oragenics, Inc. (NYSE MKT: OGEN) (the “Company”) announced today that it has completed its previously announced underwritten public offering of 4,400,000 shares of common stock at a public offering price...

Oragenics Prices Public Offering Of Common Stock

Oragenics Prices Public Offering Of Common Stock

Oragenics, Inc. (NYSE MKT: OGEN) (the “Company”) announced today that it has priced an underwritten public offering of 4,400,000 shares of its common stock at a public offering price of $2.

Oragenics Announces Proposed Public Offering Of Common Stock

Oragenics Announces Proposed Public Offering Of Common Stock

Oragenics, Inc. (NYSE MKT: OGEN) today announced its intention to offer and sell shares of its common stock in an underwritten public offering pursuant to its existing shelf registration statement.

Oragenics Announces Breakthrough Antibiotic Analog Generation In Intrexon Collaboration

Oragenics Announces Breakthrough Antibiotic Analog Generation In Intrexon Collaboration

Oragenics, Inc. (NYSE MKT: OGEN) announced today that through its Exclusive Channel Collaboration (ECC) with Intrexon Corporation (NYSE:XON), a leader in synthetic biology, it has successfully engineered a...

Top Insider Trades: ACHN PARR OPHT OGEN

Top Insider Trades: ACHN PARR OPHT OGEN

The top 10 open-market insider purchases and sales filed at the SEC Wednesday.

Oragenics Collaboration Demonstrates Initial Success In The Second Phase Of Lantibiotics Project

Oragenics Collaboration Demonstrates Initial Success In The Second Phase Of Lantibiotics Project

Oragenics, Inc. (NYSE MKT: OGEN) announced today that through its Exclusive Channel Collaboration (ECC) with Intrexon Corporation (NYSE:XON), a synthetic biology company, preliminary experiments demonstrate...

Oragenics To Join The Russell Microcap® Index

Oragenics To Join The Russell Microcap® Index

Oragenics, Inc. (NYSE MKT:OGEN), a healthcare company focused on becoming the world leader in novel antibiotics against infectious disease and probiotcs for oral health, announced today that it will be included in the...

Oragenics Receives First European Patent For ProBiora3® Probiotic Blend

Oragenics Receives First European Patent For ProBiora3® Probiotic Blend

Oragenics, Inc. (OTCQB: OGEN)(OTCBB: OGEN) today announced it has received its first patent approval in Europe for its ProBiora3® products.

Oragenics-Intrexon Collaboration Announces Significant Progress Towards Commercial Production Of Lead Lantibiotic MU1140

Oragenics-Intrexon Collaboration Announces Significant Progress Towards Commercial Production Of Lead Lantibiotic MU1140

Oragenics, Inc. (OTCBB: OGEN) announced today that its Exclusive Channel Collaboration (ECC) with Intrexon Corporation, a synthetic biology company, has produced an exponential increase in the fermentation...

Oragenics Receives European Union CPNP Notifications For ProBiora3® Cosmetic Tablets

Oragenics Receives European Union CPNP Notifications For ProBiora3® Cosmetic Tablets

Oragenics, Inc. (OTCQB: OGEN) (OTCBB: OGEN), today announced its ProBiora3® tablets intended to freshen breath, whiten teeth and contribute to overall oral health has successfully completed an independent third ...

John N. Bonfiglio, PhD President And CEO Oragenics, Inc. (Photo: Business Wire)

John N. Bonfiglio, PhD President And CEO Oragenics, Inc. (Photo: Business Wire)

Oragenics, Inc. (OTCQB:OGEN) (OTCBB: OGEN), today announced Dr.

Oragenics Announces New Strategic Partnership With Japanese-Based Company, Organic Wave, Inc. Dba KYB America

Oragenics Announces New Strategic Partnership With Japanese-Based Company, Organic Wave, Inc. Dba KYB America

Oragenics, Inc. (OTCQB: OGEN) (OTCBB: OGEN) (the “Company”), a world leader in oral care probiotics, today announced that the Company has entered into a new three year contract agreement with Organic Wave,...

John N. Bonfiglio, PhD President And CEO Oragenics, Inc. (Photo: Business Wire)

John N. Bonfiglio, PhD President And CEO Oragenics, Inc. (Photo: Business Wire)

Oragenics, Inc. (OTCQB:OGEN) (OTCBB:OGEN), today announced Dr.